CIK 0000908259 · Non-accelerated filer<br>Smaller reporting company
Oncotelic Therapeutics, Inc.
Sign in to watch- Ticker
- OTLC
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133679168
- Phone
- 650-635-7000
- Business address
- 29397 AGOURA RD., #107, AGUORA HILLS, CA, 91301
- Former names
- MATEON THERAPEUTICS INC, OXIGENE INC
- Open-market buys, last 90 days
- $23,537
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$23,537. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-29 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +1,044,990 | $0.02 | $18K | 95,481,309 |
| 2026-10-28 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +312,000 | $0.02 | $6K | 94,436,319 |
| 2026-07-10 | Fein Seymour Howard CRO/CMO | Grant or award · Restricted stock Units | +250 | 250 | ||
| 2026-07-10 | KING STEVEN W Director | Grant or award · Restricted stock Units | +250 | 250 | ||
| 2026-07-10 | MAIDA ANTHONY E III DIRECTOR AND CMO - TRANS. MED. | Grant or award · Restricted stock Units | +1,500 | 1,500 | ||
| 2026-07-10 | Saund Saran CBO | Grant or award · Restricted stock Units | +1,500 | 1,500 | ||
| 2026-07-10 | Shah Amit B. CFO | Grant or award · Restricted stock Units | +1,500 | 1,500 | ||
| 2026-07-10 | Trieu Vuong CHAIRMAN AND CEO | Grant or award · Restricted stock Units | +2,000 | 2,000 | ||
| 2026-07-01 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +240,000 | $0.04 | $10K | 94,124,319 |
| 2026-06-24 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +115,000 | $0.05 | $5K | 93,884,319 |
| 2026-06-23 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +75,000 | $0.05 | $3K | 93,769,319 |
| 2026-06-22 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +65,000 | $0.05 | $3K | 93,694,319 |
| 2026-06-22 | Shah Amit B. CFO | Purchase | +20,000 | $0.05 | $1K | 378,837 |
| 2026-06-17 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +239,759 | $0.04 | $11K | 93,629,319 |
| 2026-06-15 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +96,000 | $0.05 | $4K | 93,389,560 |
| 2026-01-22 | Trieu Vuong CHAIRMAN AND CEO | Grant or award · Series A Convertible Preferred Stock | +4,426 | 8,491 | ||
| 2025-11-17 | Trieu Vuong CHAIRMAN AND CEO | Grant or award · Series A Convertible Preferred Stock | +4,065 | 4,065 | ||
| 2025-07-10 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +104,000 | $0.01 | $520 | 93,293,560 |
| 2025-07-09 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +1 | $0.01 | $0 | 93,293,561 |
| 2025-07-08 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +94,736 | $0.01 | $474 | 93,388,297 |
Page 1 of 7 · 140 trades